In the face of growing chloroquine resistance of Plasmodium falciparum, efforts to prolong the clinical usefulness of the drug have partly concentrated on its combination with potential resistance-reversing compounds. However, clinical studies on such combinations have been limited. We have compared
Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children
โ Scribed by A. Sowunmi; A.M.J. Oduola; O.A.T. Ogundahunsi; L.A. Salako
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 647 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0035-9203
No coin nor oath required. For personal study only.
โฆ Synopsis
The efficacy of pyrimethamineisulfadoxine (I'S) and chloroquine plus chlorpheniramine, a histamine H1 receptor blocker which reverses chloroquine insensitivity in Plasmodium falciparum in vitro, was evaluated in 100 consecutive children with acute symptomatic uncomplicated falciparum malaria. Parasitaemia on day 3 following initiation of treatment, fever and symptom clearance times were significantly lower in the chloroquineichlorpheniramine (CQICP) combination group than in the PS group.The cure rate was also significantly higher in the combination group.The combination cured all children who had failed I'S treatment. Gametocytaemia and the gametocyte carrier rate following therapy were significantly lower in the combination group than in those receiving I?% Both treatments were well tolerated but adverse drug reactions were commoner in the children given PS. CQiCP is effective in I'S treatment failure in Nigerian children and may be useful for this condition in African children in general.
๐ SIMILAR VOLUMES
Chlorpheniramine, a histamine HI receptor antagonist, reverses chloroquine resistance in Plasmodium falciaarum in vitro. However. the clinical sianificance of this remains unclear. We have evaluated the efficacv of chloroquine and a chloroquine-chlorbheniramine combination in 112 consecutive childre
The cardiac effects ofhalofantrine (HF) and chloroquine plus chlorpheniramine (CQ-CP), a histamine Hi antagonist which reverses chloroquine insensitivity in Plasmodium falciparum in vitro and in vivo, were assessed in 41 children with acute svmntomatic uncomnlicated P fa&arum malaria bv electrocardi
Artemisinin derivatives, such as artesunate, have a short half-life and very rapid anti-malarial activity. Theoretically, using such agents in conjunction with well-established anti-malarial drugs such as sulfadoxine-pyrimethamine may reduce the rate of drug resistance. Such a combination has not pr